Mortality Among Persons With Obsessive-Compulsive Disorder in Denmark.
paper
Cited
Public
- Authors
- Meier, Sandra M; Mattheisen, Manuel; Mors, Ole; Schendel, Diana E; Mortensen, Preben B; Plessen, Kerstin J
- Year
- 2016
- Journal
- JAMA psychiatry
- PMID
- 26818216
- DOI
- 10.1001/jamapsychiatry.2015.3105
- PMCID
- PMC5082974
IMPORTANCE: Several mental disorders have consistently been found to be associated with decreased life expectancy, but little is known about whether this is also the case for obsessive-compulsive disorder (OCD). OBJECTIVE: To determine whether persons who receive a diagnosis of OCD are at increased risk of death. DESIGN, SETTING, AND PARTICIPANTS: Using data from Danish registers, we conducted a nationwide prospective cohort study with 30 million person-years of follow-up. The data were collected from Danish longitudinal registers. A total of 3 million people born between 1955 and 2006 were followed up from January 1, 2002, through December 31, 2011. During this period, 27,236 people died. The data were analyzed primarily in June 2015. MAIN OUTCOMES AND MEASURES: We estimated mortality rate ratios (MRRs), adjusted for calendar year, age, sex, maternal and paternal age, place of residence at birth, and somatic comorbidities, to compare persons with OCT with persons without OCD. RESULTS: Of 10,155 persons with OCD (5935 women and 4220 men with a mean [SD] age of 29.1 [11.3] years who contributed a total of 54,937 person-years of observation), 110 (1.1%) died during the average follow-up of 9.7 years. The risk of death by natural or unnatural causes was significantly higher among persons with OCD (MRR, 1.68 [95% CI, 1.31-2.12] for natural causes; MRR, 2.61 [95% CI, 1.91-3.47] for unnatural causes) than among the general population. After the exclusion of persons with comorbid anxiety disorders, depression, or substance use disorders, OCD was still associated with increased mortality risk (MRR, 1.88 [95% CI, 1.27-2.67]). CONCLUSIONS AND RELEVANCE: The presence of OCD was associated with a significantly increased mortality risk. Comorbid anxiety disorders, depression, or substance use disorders further increased the risk. However, after adjusting for these and somatic comorbidities, we found that the mortality risk remained significantly increased among persons with OCD.
Mortality Rate Ratios of Persons With Pure or Comorbid OCD (2002–2011)Mortality rate ratios were adjusted for calendar year, age, sex, maternal and paternal age, place of residence at time of birth, somatic comorbidity, and the interaction of age and sex. “Pure” obsessive-compulsive disorder (OCD) indicates OCD without comorbidities. Comorbidities include anxiety disorders, depression, and substance abuse disorders.
1–20 of 24
Next →
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder. | 2025 | 40360802 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Accuracy, reach, and content quality of information about obsessive-compulsive disorder on TikTok. | Cheng JS et al. | — | 2025 | → |
| Association Between Polygenic Risk and Symptom Severity Change After Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder. | Bäckman J et al. | — | 2025 | → |
| Characterizing Rare DNA Copy-Number Variants in Pediatric Obsessive-Compulsive Disorder. | Abdallah SB et al. | — | 2025 | → |
| Dual Frameworks for Understanding OCD: Cognitive Misappraisals and Psychological Inflexibility in Clinical and Non-Clinical Populations. | Soumee ZN et al. | — | 2025 | → |
| Evaluation of potential biomarker miRNAs and the levels of serotonin and dopamine in female patients with obsessive-compulsive disorder. | Korkmaz ND et al. | — | 2025 | → |
| Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder. | Strom NI et al. | — | 2025 | → |
| Implementing early care protocol for obsessive-compulsive disorder: A scalable model for public mental health services. | Cuevas Yust C et al. | — | 2025 | → |
| Neurometabolic dysregulation within the cortico-striatal-thalamo-cortical circuits in obsessive-compulsive disorder: A <sup>1</sup>H-MRS meta-analysis. | Zhu F et al. | — | 2025 | → |
| Obsessive-compulsive disorder - A state-of-the-art review. | Endres D et al. | — | 2025 | → |
| Obsessive-compulsive symptoms and related risk and protective factors in Black individuals in Canada. | Dromer E et al. | — | 2025 | → |
| Prediction of unfavorable outcome of acute decompensation of diabetes mellitus. | Kogan LP et al. | — | 2025 | → |
| Prevention of obsessive-compulsive disorder in at-risk children: A feasibility trial | Aspvall K et al. | — | 2025 | — |
| Sociodemographic, mental health, education, employment and income characteristics of adults with obsessive-compulsive disorder who accessed secondary health services in Aotearoa | New Zealand. | McLeod K et al. | — | 2025 | → |
| All cause and cause specific mortality in obsessive-compulsive disorder: nationwide matched cohort and sibling cohort study. | Fernández de la Cruz L et al. | — | 2024 | → |
| A systematic review of structural neuroimaging markers of psychotherapeutic and pharmacological treatment for obsessive-compulsive disorder. | Moreau AL et al. | — | 2024 | → |
| Clinical dimensions of people with co-occurring obsessive-compulsive and related disorders and multiple sclerosis: a scoping review protocol. | Freedman DE et al. | — | 2024 | → |
| Cognitive Rehabilitation for Adult Patients With Obsessive-compulsive Disorder: A Systematic Review of Randomized Controlled Trials. | Bakizadeh F et al. | — | 2024 | → |
| General somatic health and lifestyle habits in individuals with obsessive- compulsive disorder: an international survey. | Holmberg A et al. | — | 2024 | → |
| Identification of key mRNAs and signaling pathways in obsessive compulsive disorder based on weighted gene co-expression network analysis and cytoHubba plugin. | Zhang X et al. | — | 2024 | → |
| Neurosurgical neuromodulation therapy for psychiatric disorders. | Ranjan M et al. | — | 2024 | → |
| Obsessive-compulsive disorder and suicide: a longitudinal study in Taiwan. | Chen MH et al. | — | 2024 | → |
| Polysomnographic changes of obsessive-compulsive disorder: evidence from case-control studies. | Nie Y et al. | — | 2024 | → |
| Targeting the prefrontal-supplementary motor network in obsessive-compulsive disorder with intensified electrical stimulation in two dosages: a randomized, controlled trial. | Alizadehgoradel J et al. | — | 2024 | → |
| The acceptability of lifestyle medicine for the treatment of mental illness: perspectives of people with and without lived experience of mental illness. | Richardson K et al. | — | 2024 | → |
| The persistent value of lesions in psychiatric neurosurgery. | Abdulrazeq H et al. | — | 2024 | → |
| Association between obsessive-compulsive disorder and the risk of schizophrenia using the Korean National Health Insurance Service-National Sample Cohort: a retrospective cohort study. | Kim H et al. | — | 2023 | → |
| Do Autistic Traits Predict Outcome of Cognitive Behavioral Therapy in Pediatric Obsessive-Compulsive Disorder? | Højgaard DRMA et al. | — | 2023 | → |
| Lifespan variation among people with a given disease or condition. | Zheng Y et al. | — | 2023 | → |
| Lifestyle risk factors for obsessive-compulsive symptoms and related phenomena: What should lifestyle interventions target? | Brierley ME et al. | — | 2023 | → |
| Population-attributable risk of psychiatric disorders for suicide among adolescents and young adults in Taiwan. | Hung YA et al. | — | 2023 | → |
| Predicting obsessive-compulsive disorder episodes in adolescents using a wearable biosensor-A wrist angel feasibility study. | Lønfeldt NN et al. | — | 2023 | → |
| Prevalence and correlates of lifetime suicide attempt in obsessive-compulsive disorder with major depression. | Samuels J et al. | — | 2023 | → |
| Associations Between the Severity of Obsessive-Compulsive Disorder and Vocal Features in Children and Adolescents: Protocol for a Statistical and Machine Learning Analysis. | Clemmensen LKH et al. | — | 2022 | → |
| Brain Structures and Networks Underlying Treatment Response to Deep Brain Stimulation Targeting the Inferior Thalamic Peduncle in Obsessive-Compulsive Disorder. | Germann J et al. | — | 2022 | → |
| Cognitive Outcome After Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder: A Systematic Review. | Bouwens van der Vlis TAM et al. | — | 2022 | → |
| Co-occurring depression and obsessive-compulsive disorder: A dimensional network approach. | Hellberg SN et al. | — | 2022 | → |
| Efficacy of Non-Invasive Brain Stimulation for Refractory Obsessive-Compulsive Disorder: A Meta-Analysis of Randomized Controlled Trials. | Zhou S et al. | — | 2022 | → |
| Electroconvulsive therapy for obsessive-compulsive disorder: A retrospective study. | Li K et al. | — | 2022 | → |
| Morbidity and mortality in obsessive-compulsive disorder: A narrative review. | Fernández de la Cruz L et al. | — | 2022 | → |
| Mortality in people with mental disorders in Poland: A nationwide, register-based cohort study. | Kiejna A et al. | — | 2022 | → |
| Obsessive-Compulsive Disorder and Schizophrenia: Conceptualization, Assessment and Cognitive Behavioral Treatment. | Hudak R et al. | — | 2022 | → |
| The prefrontal cortex and neurosurgical treatment for intractable OCD. | Rasmussen SA et al. | — | 2022 | → |
| The prefrontal cortex and OCD. | Ahmari SE et al. | — | 2022 | → |
| The role of early-life family composition and parental socio-economic status as risk factors for obsessive-compulsive disorder in a Danish national cohort. | Yilmaz Z et al. | — | 2022 | → |
| Through the prism of comorbidity: A strategic rethinking of early intervention in obsessive-compulsive disorder. | Preti A et al. | — | 2022 | → |
| A narrative review of exercise and obsessive-compulsive disorder. | Freedman DE et al. | — | 2021 | → |
| Cellular and Extracellular White Matter Abnormalities in Obsessive-Compulsive Disorder: A Diffusion Magnetic Resonance Imaging Study. | Maziero MP et al. | — | 2021 | → |
| Correlates of obsessive-compulsive and related disorders symptom severity during the COVID-19 pandemic. | Fontenelle LF et al. | — | 2021 | → |
| Cost-effectiveness of Internet-Delivered vs In-Person Cognitive Behavioral Therapy for Children and Adolescents With Obsessive-Compulsive Disorder. | Aspvall K et al. | — | 2021 | → |
| Defining and Addressing Gaps in Care for Obsessive-Compulsive Disorder in the United States. | Senter MS et al. | — | 2021 | → |
| Elevated C-reactive protein levels across diagnoses: The first comparison among inpatients with major depressive disorder, bipolar disorder, or obsessive-compulsive disorder. | Caldirola D et al. | — | 2021 | → |
| Genetic and environmental sources of familial coaggregation of obsessive-compulsive disorder and suicidal behavior: a population-based birth cohort and family study. | Sidorchuk A et al. | — | 2021 | → |
| Genetics of obsessive-compulsive disorder. | Mahjani B et al. | — | 2021 | → |
| Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder. | Goodman WK et al. | — | 2021 | → |
| Immediate reactions to the covid-19 pandemic in adults with obsessive-compulsive disorder: a self-report survey. | Højgaard DRMA et al. | — | 2021 | → |
| Lifestyle Interventions in the Treatment of Obsessive-Compulsive and Related Disorders: A Systematic Review. | Brierley ME et al. | — | 2021 | → |
| Long-Term Cost-Effectiveness of Smoking Cessation Interventions in People With Mental Disorders: A Dynamic Decision Analytical Model. | Wu Q et al. | — | 2021 | → |
| Pharmacological and Psychotherapeutic Interventions for Management of Obsessive-compulsive Disorder in Adults: A Systematic Review and Network Meta-analysis. | Skapinakis P et al. | — | 2021 | → |
| Risk of specific cardiovascular diseases in obsessive-compulsive disorder. | Isomura K et al. | — | 2021 | → |
| Selective Serotonin Reuptake Inhibitors: How Long Is Long Enough? | Thom RP et al. | — | 2021 | → |
| Cutting-edge genetics in obsessive-compulsive disorder. | Saraiva LC et al. | — | 2020 | → |
| Deep Brain Stimulation for Refractory Depression, Obsessive-Compulsive Disorder and Addiction. | Ranjan M et al. | — | 2020 | → |
| De Novo Damaging DNA Coding Mutations Are Associated With Obsessive-Compulsive Disorder and Overlap With Tourette's Disorder and Autism. | Cappi C et al. | — | 2020 | → |
| Impulsivity, hostility and suicidality in patients diagnosed with obsessive compulsive disorder. | Nagy NE et al. | — | 2020 | → |
| Socio-demographic and psychiatric risk factors in incident and persistent depression: An analysis in the occupational cohort of ELSA-Brasil. | Brunoni AR et al. | — | 2020 | → |
| Suicide attempts and suicidal ideation in patients with obsessive-compulsive disorder: A systematic review and meta-analysis. | Pellegrini L et al. | — | 2020 | → |
| Toward identifying reproducible brain signatures of obsessive-compulsive profiles: rationale and methods for a new global initiative. | Simpson HB et al. | — | 2020 | → |
| When Improving Symptoms Is Not Enough-Is It Time for Next-Generation Interventions for Obsessive-Compulsive Disorder? | Mataix-Cols D et al. | — | 2020 | → |
| A systematic review of the use of risperidone, paliperidone and aripiprazole as augmenting agents for obsessive-compulsive disorder. | Brakoulias V et al. | — | 2019 | → |
| Comparative effectiveness of neuroablation and deep brain stimulation for treatment-resistant obsessive-compulsive disorder: a meta-analytic study. | Kumar KK et al. | — | 2019 | → |
| Directionality of change in obsessive compulsive disorder (OCD) and suicidal ideation over six years in a naturalistic clinical sample<sup>✰</sup>. | Brown LA et al. | — | 2019 | → |
| Evolution of gamma knife capsulotomy for intractable obsessive-compulsive disorder. | Miguel EC et al. | — | 2019 | → |
| Neural circuitry and precision medicines for mental disorders: are they compatible? | Dean CE | — | 2019 | → |
| Obsessive-compulsive disorder. | Stein DJ et al. | — | 2019 | → |
| Perceived physical health in obsessive-compulsive disorder: a protocol for a systematic review and meta-analysis. | Pozza A et al. | — | 2019 | → |
| Prevalence, comorbidity, quality of life and use of services of obsessive-compulsive disorder and subthreshold obsessive-compulsive symptoms in the general adult population of Greece. | Skapinakis P et al. | — | 2019 | → |
| Suicide Risk in Obsessive-Compulsive Disorder and Exploration of Risk Factors: A Systematic Review. | Albert U et al. | — | 2019 | → |
| The association between mental disorders and suicide: A systematic review and meta-analysis of record linkage studies. | Too LS et al. | — | 2019 | → |
| The Perception of Physical Health Status in Obsessive-Compulsive Disorder: A Systematic Review and Meta-Analysis. | Pozza A et al. | — | 2019 | → |
| Use of an Individual-Level Approach to Identify Cortical Connectivity Biomarkers in Obsessive-Compulsive Disorder. | Brennan BP et al. | — | 2019 | → |
| Errors in Table 1. | — | — | 2018 | → |
| How can preclinical mouse models be used to gain insight into prefrontal cortex dysfunction in obsessive-compulsive disorder? | Manning EE et al. | — | 2018 | → |
| Metabolic and Cardiovascular Complications in Obsessive-Compulsive Disorder: A Total Population, Sibling Comparison Study With Long-Term Follow-up. | Isomura K et al. | — | 2018 | → |
| Pedophilia-Themed Obsessive-Compulsive Disorder: Assessment, Differential Diagnosis, and Treatment with Exposure and Response Prevention. | Bruce SL et al. | — | 2018 | → |
| Demographic and health-related correlates of obsessive-compulsive symptoms among African Americans. | Williams MT et al. | — | 2017 | → |
| Mit fünf Fragen erkennen Sie die Zwangsstörung. | Müller T | — | 2017 | → |
| Mortality risk in a nationwide cohort of individuals with tic disorders and with tourette syndrome. | Meier SM et al. | — | 2017 | → |
| Suicide in obsessive-compulsive disorder: a population-based study of 36 788 Swedish patients. | Fernández de la Cruz L et al. | — | 2017 | → |
| The cost-effectiveness of deep brain stimulation for patients with treatment-resistant obsessive-compulsive disorder. | Moon W et al. | — | 2017 | → |
| Underdiagnosed chronic somatic illnesses in patients with severe mental disorder. | Rodríguez-Leal CM et al. | — | 2017 | → |
| Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. | Skapinakis P et al. | — | 2016 | → |